Next Article in Journal
Mechanochemical Formation of Racemic Praziquantel Hemihydrate with Improved Biopharmaceutical Properties
Previous Article in Journal
Quality by Design: Development of the Quality Target Product Profile (QTPP) for Semisolid Topical Products
Open AccessReview

Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review

1
Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah 27272, UAE
2
Research Institute of Medical & Health Sciences, University of Sharjah, Sharjah 27272, UAE
3
NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain
4
University Institute for Regenerative Medicine and Oral Implantology—UIRMI (UPV/EHU-Fundación Eduardo Anitua), 01006 Vitoria, Spain
*
Author to whom correspondence should be addressed.
Pharmaceutics 2020, 12(3), 288; https://doi.org/10.3390/pharmaceutics12030288
Received: 10 February 2020 / Revised: 7 March 2020 / Accepted: 14 March 2020 / Published: 23 March 2020
The efficacy of current standard chemotherapy is suboptimal due to the poor solubility and short half-lives of chemotherapeutic agents, as well as their high toxicity and lack of specificity which may result in severe side effects, noncompliance and patient inconvenience. The application of nanotechnology has revolutionized the pharmaceutical industry and attracted increasing attention as a significant means for optimizing the delivery of chemotherapeutic agents and enhancing their efficiency and safety profiles. Nanostructured lipid carriers (NLCs) are lipid-based formulations that have been broadly studied as drug delivery systems. They have a solid matrix at room temperature and are considered superior to many other traditional lipid-based nanocarriers such as nanoemulsions, liposomes and solid lipid nanoparticles (SLNs) due to their enhanced physical stability, improved drug loading capacity, and biocompatibility. This review focuses on the latest advances in the use of NLCs as drug delivery systems and their preparation and characterization techniques with special emphasis on their applications as delivery systems for chemotherapeutic agents and different strategies for their use in tumor targeting. View Full-Text
Keywords: nanostructured lipid carriers; chemotherapeutic agents; drug delivery systems; drug targeting; lipid-based nanoparticles nanostructured lipid carriers; chemotherapeutic agents; drug delivery systems; drug targeting; lipid-based nanoparticles
Show Figures

Graphical abstract

MDPI and ACS Style

Haider, M.; Abdin, S.M.; Kamal, L.; Orive, G. Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review. Pharmaceutics 2020, 12, 288.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop